Results 21 to 30 of about 4,278 (174)

Evaluation and comparison of semaphorin 4D levels in saliva of periodontally healthy and Stage 1 Grade A periodontitis patients and its response to nonsurgical periodontal treatment: A clinicobiochemical interventional study

open access: yesJournal of Indian Society of Periodontology
Background: Salivary biomarkers have the potential to be used as diagnostic tools for periodontal disease. This study aimed to evaluate the role of semaphorin 4D (SEMA4D) in saliva among healthy and periodontitis subjects and its response to nonsurgical ...
Bela Nagasmal Khobragade   +4 more
doaj   +2 more sources

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients [PDF]

open access: yesJournal of Bone Oncology, 2019
Background: Semaphorin 4D (Sema4D) is a glycoprotein that inhibits bone formation and has been associated with cancer progression and the occurrence of bone metastases.
Andy Göbel   +11 more
doaj   +2 more sources

Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma

open access: yesNeoplasia: An International Journal for Oncology Research, 2017
The semaphorins and the plexins are a family of large, cysteine-rich proteins originally identified as regulators of axon growth and lymphocyte activation that are now known to provide motility and positional information for a number of cell and tissue ...
Hua Zhou   +6 more
doaj   +2 more sources

Inflammatory Semaphorins in the Pathogenesis and Prognosis of Acute Ischemic Stroke [PDF]

open access: yesMedicina
Background and Objectives: Semaphorins are immunoregulatory proteins involved in inflammation and neurovascular modulation. Their roles in ischemic stroke pathogenesis and prognosis have recently gained attention.
Esen Çiçekli   +2 more
doaj   +2 more sources

Effect of Nutritional Deprivation after Sleeve Gastrectomy on Bone Mass, Periostin, Sclerostin and Semaphorin 4D: A Two-Year Longitudinal Study. [PDF]

open access: yesNutrients, 2023
International audienceBariatric surgery induces bone loss, but the exact mechanisms by which this process occurs are not fully known. The aims of this 2-year longitudinal study were to (i) investigate the changes in areal bone mineral density (aBMD) and ...
Maïmoun L   +13 more
europepmc   +2 more sources

Semaphorin 4D is expressed constitutively by human eosinophils

open access: yesAllergology International, 2015
Yukiko Hiraguchi   +5 more
doaj   +3 more sources

Dual-Function Semaphorin 4D Released by Platelets: Suppression of Osteoblastogenesis and Promotion of Osteoclastogenesis. [PDF]

open access: yesInt J Mol Sci, 2022
Effects of the antiosteoblastogenesis factor Semaphorin 4D (Sema4D), expressed by thrombin-activated platelets (TPs), on osteoblastogenesis, as well as osteoclastogenesis, were investigated in vitro.
Shindo S   +13 more
europepmc   +2 more sources

Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. [PDF]

open access: yesAngiogenesis, 2012
The semaphorins and plexins comprise a family of cysteine-rich proteins implicated in control of nerve growth and development and regulation of the immune response. Our group and others have found that Semaphorin 4D (SEMA4D) and its receptor, Plexin-B1, play an important role in tumor-induced angiogenesis, with some neoplasms producing SEMA4D in a ...
Hua, Zhou   +4 more
core   +4 more sources

Anti-Semaphorin 4D Rescues Motor, Cognitive, and Respiratory Phenotypes in a Rett Syndrome Mouse Model. [PDF]

open access: yesInt J Mol Sci, 2021
Rett syndrome is a neurodevelopmental disorder caused by mutations of the methyl-CpG binding protein 2 gene. Abnormal physiological functions of glial cells contribute to pathogenesis of Rett syndrome.
Mao Y   +6 more
europepmc   +2 more sources

Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease

open access: yesNeurobiology of Disease, 2015
Huntington disease (HD) is an inherited, fatal neurodegenerative disease with no disease-modifying therapy currently available. In addition to characteristic motor deficits and atrophy of the caudate nucleus, signature hallmarks of HD include behavioral ...
Amber L. Southwell   +16 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy